Jeffrey A. Munsie
2017
In 2017, Jeffrey A. Munsie earned a total compensation of $1.3M as General Counsel, Head of Corporate Operations and Secretary at Merrimack Pharmaceuticals.
Compensation breakdown
| Bonus | $350,000 |
|---|---|
| Non-Equity Incentive Plan | $132,300 |
| Option Awards | $476,960 |
| Salary | $338,706 |
| Other | $13,368 |
| Total | $1,311,334 |
Munsie received $477K in option awards, accounting for 36% of the total pay in 2017.
Munsie also received $350K in bonus, $132.3K in non-equity incentive plan, $338.7K in salary and $13.4K in other compensation.
Rankings
In 2017, Jeffrey A. Munsie's compensation ranked 7,677th out of 14,666 executives tracked by ExecPay. In other words, Munsie earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,677 out of 14,666 | 48th |
Division Manufacturing | 2,872 out of 5,772 | 50th |
Major group Chemicals And Allied Products | 932 out of 2,075 | 55th |
Industry group Drugs | 721 out of 1,731 | 58th |
Industry Pharmaceutical Preparations | 562 out of 1,333 | 58th |
Source: SEC filing on April 27, 2018.
Munsie's colleagues
We found six more compensation records of executives who worked with Jeffrey A. Munsie at Merrimack Pharmaceuticals in 2017.
2017
Richard Peters
Merrimack Pharmaceuticals
Chief Executive Officer
2017
Daryl Drummond
Merrimack Pharmaceuticals
Head of Research
2017
Sergio Santillana
Merrimack Pharmaceuticals
Chief Medical Officer
2017
Jean Franchi
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Yasir Al-Wakeel
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Gary Crocker
Merrimack Pharmaceuticals